GCN2 is a
protein kinase in Saccharomyces cerevisiae that is required for increased expression of the transcriptional activator GCN4 in
amino acid-starved cells. GCN2 stimulates GCN4 synthesis at the translational level by phosphorylating the alpha subunit of eukaryotic translation
initiation factor 2 (eIF-2). We identified a truncated form of the GLC7 gene, encoding the catalytic subunit of a type 1
protein phosphatase, by its ability to restore derepression of GCN4 expression in a strain containing the partially defective gcn2-507 allele. Genetic analysis suggests that the truncated GLC7 allele has a dominant negative phenotype, reducing the level of native type 1
protein phosphatase activity in the cell. The truncated form of GLC7 does not suppress the regulatory defect associated with a gcn2 deletion or a mutation in the phosphorylation site of
eIF-2 alpha (Ser-51). In addition, the presence of multiple copies of wild-type GLC7 impairs the derepression of GCN4 that occurs in response to
amino acid starvation or dominant-activating mutations in GCN2. These findings suggest that the
phosphatase activity of GLC7 acts in opposition to the
kinase activity of GCN2 in modulating the level of
eIF-2 alpha phosphorylation and the translational efficiency of GCN4
mRNA. This conclusion is supported by biochemical studies showing that the truncated GLC7 allele increases the level of
eIF-2 alpha phosphorylation in the gcn2-507 mutant to a level approaching that seen in wild-type cells under
starvation conditions. The truncated GLC7 allele also leads to reduced
glycogen accumulation, indicating that this
protein phosphatase is involved in regulating diverse metabolic pathways in yeast cells.